tiprankstipranks
Med Biogene Inc (TSE:MBI.H)
TSXV:MBI.H
Canadian Market
Holding TSE:MBI.H?
Track your performance easily

Med Biogene (MBI.H) Financial Statements

4 Followers

Med Biogene Financial Overview

Med Biogene's market cap is currently ―. The company's EPS TTM is C$-0.004; its P/E ratio is -6.82; Med Biogene is scheduled to report earnings on April 18, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -20.00K$ -10.13K$ -11.22K$ -15.01K$ -20.60K
EBITDA$ -20.00K$ -10.13K$ -11.22K$ -15.01K$ -20.60K
Net Income Common Stockholders$ -20.00K$ -10.13K$ -11.22K$ -15.01K$ -20.60K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 143.00$ 1.02K$ 713.00$ 208.00$ 1.16K
Total Assets$ 10.14K$ 14.22K$ 2.31K$ 6.46K$ 12.77K
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -143.00$ -1.02K$ -713.00$ -208.00$ -1.16K
Total Liabilities$ 162.93K$ 148.33K$ 129.30K$ 119.44K$ 112.88K
Stockholders Equity$ -152.78K$ -134.10K$ -126.98K$ -112.98K$ -100.11K
Cash Flow-
Free Cash Flow$ -2.20K$ -2.71K$ 3.29K$ -3.09K$ 2.38K
Operating Cash Flow$ -2.20K$ -2.71K$ 3.29K$ -3.09K$ 2.38K
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Med Biogene Earnings and Revenue History

Med Biogene Debt to Assets

Med Biogene Cash Flow

Med Biogene Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis